NASDAQ:CLRB
Cellectar Biosciences, Inc.
- Stock
Last Close
3.43
06/11 22:11
Market Cap
84.24M
Beta: 1.17
Volume Today
359.90K
Avg: 55.21K
PE Ratio
−1.03
PFCF: −1.36
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -8.11M - | -5.50M 32.21% | -6.18M 12.47% | -13.56M 119.44% | -13.24M 2.38% | -14.09M 6.45% | -15.09M 7.10% | -24.12M 59.81% | -28.60M 18.57% | -37.98M 32.80% | |
depreciation and amortization | 367.20K - | 362.50K 1.28% | 356.67K 1.61% | 1.55M 333.47% | 82.27K 94.68% | 132.80K 61.43% | 141.45K 6.52% | 149.91K 5.98% | 148.44K 0.99% | 192.38K 29.60% | |
deferred income tax | -2.23M - | -3.71M 66.45% | -3.79M 2.19% | -43K - | -185.28K 330.88% | 2.94K 101.59% | -39.08M - | ||||
stock based compensation | 850.35K - | 447.30K 47.40% | 529.16K 18.30% | 758.76K 43.39% | 721.21K 4.95% | 866.79K 20.19% | 467.54K 46.06% | 1.12M 140.45% | 1.45M 29.25% | 2.41M 65.89% | |
change in working capital | -149.49K - | -265.52K 77.61% | 273.81K 203.12% | 259.26K 5.32% | -569.05K 319.49% | 1.39M 343.57% | 671.24K 51.57% | 198.76K 70.39% | 1.68M 747.12% | 3.70M 119.76% | |
accounts receivables | |||||||||||
inventory | |||||||||||
accounts payables | -228.11K - | -258.06K 13.13% | 740.51K 386.95% | 451.32K 39.05% | -258.79K 157.34% | 1.12M 532.80% | 780.60K 30.31% | 411.72K 47.26% | 1.62M 294.33% | 3.70M 127.91% | |
other working capital | 78.62K - | -7.45K 109.48% | -466.70K 6,161.85% | -192.07K 58.85% | -310.26K 61.54% | 266.00K 185.73% | -109.36K 141.11% | -212.96K 94.72% | 60.21K 128.27% | -3.70M 6,245.80% | |
other non cash items | 426.46K - | 447.30K 4.89% | 529.16K 18.30% | -22.07K 104.17% | 1.56M 7,178.21% | 56.56K 96.38% | 66.48K 17.53% | 77.72K 16.92% | 93.82K 20.71% | -3.70M 4,044.02% | |
net cash provided by operating activities | -8.84M - | -8.21M 7.10% | -8.28M 0.84% | -11.02M 33.06% | -11.44M 3.83% | -11.69M 2.20% | -13.93M 19.15% | -22.57M 61.98% | -25.22M 11.76% | -35.38M 40.28% | |
investments in property plant and equipment | -29.57K - | -58.47K 97.74% | -72.25K 23.57% | -346.70K 379.86% | -384.99K 11.04% | -24.54K 93.63% | -62.35K 154.07% | -141.36K 126.71% | -225.97K 59.85% | -864.04K 282.37% | |
acquisitions net | |||||||||||
purchases of investments | |||||||||||
sales maturities of investments | |||||||||||
other investing activites | 55K - | ||||||||||
net cash used for investing activites | -29.57K - | -58.47K 97.74% | -72.25K 23.57% | -346.70K 379.86% | -329.99K 4.82% | -24.54K 92.56% | -62.35K 154.07% | -141.36K 126.71% | -225.97K 59.85% | -864.04K 282.37% | |
debt repayment | -619.19K - | -122.66K 80.19% | -246.08K 100.62% | -89.32K 63.70% | -3.04K 96.60% | -2.21K 27.11% | -184K 8,214.51% | ||||
common stock issued | 12.40M - | 3.30M 73.38% | 12.32M 273.37% | 4.91M 60.18% | 9.08M 85.00% | 9.02M 0.56% | 59.72M 561.74% | 34.87K 99.94% | 9.61M 27,459.01% | 22.15M 130.47% | |
common stock repurchased | 3.71M - | 8.19M 120.53% | |||||||||
dividends paid | -1.45M - | -2.24M 54.72% | |||||||||
other financing activites | 4.10M - | -470.73K 111.49% | 3.87M 921.30% | 2.85M 26.36% | -762 100.03% | 9.02K 1,284.04% | 1.01M 11,099.90% | 1.21M 20.13% | 789.64K - | ||
net cash used provided by financing activities | 15.87M - | 2.71M 82.95% | 15.94M 488.98% | 9.93M 37.72% | 15.02M 51.29% | 9.02M 39.94% | 60.55M 571.06% | 1.25M 97.94% | 9.61M 669.59% | 22.94M 138.69% | |
effect of forex changes on cash | 3.00M - | ||||||||||
net change in cash | 7.00M - | -5.56M 179.45% | 7.59M 236.34% | -1.44M 118.96% | 3.25M 325.92% | -2.70M 182.97% | 46.55M 1,826.72% | -21.46M 146.10% | -15.84M 26.20% | -10.30M 34.96% | |
cash at beginning of period | 2.42M - | 9.42M 289.62% | 3.86M 59.06% | 11.50M 198.09% | 10.06M 12.51% | 13.31M 32.29% | 10.61M 20.25% | 57.17M 438.55% | 35.70M 37.54% | 19.87M 44.36% | |
cash at end of period | 9.42M - | 3.86M 59.06% | 11.44M 196.66% | 10.06M 12.09% | 13.31M 32.29% | 10.61M 20.25% | 57.17M 438.55% | 35.70M 37.54% | 19.87M 44.36% | 9.56M 51.85% | |
operating cash flow | -8.84M - | -8.21M 7.10% | -8.28M 0.84% | -11.02M 33.06% | -11.44M 3.83% | -11.69M 2.20% | -13.93M 19.15% | -22.57M 61.98% | -25.22M 11.76% | -35.38M 40.28% | |
capital expenditure | -29.57K - | -58.47K 97.74% | -72.25K 23.57% | -346.70K 379.86% | -384.99K 11.04% | -24.54K 93.63% | -62.35K 154.07% | -141.36K 126.71% | -225.97K 59.85% | -864.04K 282.37% | |
free cash flow | -8.87M - | -8.27M 6.75% | -8.35M 1.00% | -11.37M 36.06% | -11.83M 4.05% | -11.72M 0.92% | -14.00M 19.43% | -22.71M 62.27% | -25.45M 12.06% | -36.24M 42.43% |
All numbers in USD (except ratios and percentages)